Clifford Elow v. Express Scripts Holding Co. and Amitkumar Khandhar v. Express Scripts Holding Co.

CourtCourt of Chancery of Delaware
DecidedMay 31, 2017
Docket12721-VCMR, 12734-VCMR
StatusPublished

This text of Clifford Elow v. Express Scripts Holding Co. and Amitkumar Khandhar v. Express Scripts Holding Co. (Clifford Elow v. Express Scripts Holding Co. and Amitkumar Khandhar v. Express Scripts Holding Co.) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Clifford Elow v. Express Scripts Holding Co. and Amitkumar Khandhar v. Express Scripts Holding Co., (Del. Ct. App. 2017).

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

CLIFFORD ELOW, ) ) Plaintiff, ) ) v. ) C.A. No. 12721-VCMR ) EXPRESS SCRIPTS HOLDING ) COMPANY, ) ) Defendant. ) _______________________________ ) AMITKUMAR KHANDHAR, ) ) Plaintiff, ) C.A. No. 12734-VCMR ) v. ) ) EXPRESS SCRIPTS HOLDING ) COMPANY, ) ) Defendant. )

MEMORANDUM OPINION Date Submitted: April 26, 2017 Date Decided: May 31, 2017

Peter B. Andrews, Craig J. Springer, and David M. Sborz, ANDREWS & SPRINGER, LLC, Wilmington, Delaware; Jeffrey M. Norton and Roger A. Sachar Jr., NEWMAN FERRARA LLP, New York, New York; Attorneys for Plaintiff Clifford Elow.

Peter B. Andrews, Craig J. Springer, and David M. Sborz, ANDREWS & SPRINGER, LLC, Wilmington, Delaware; Melinda A. Nicholson and Michael R. Robinson, KAHN SWICK & FOTI, LLC, Madisonville, Louisiana; Attorneys for Plaintiff Amitkumar Khandhar. Paul J. Lockwood and Jenness E. Parker, SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP, Wilmington, Delaware; Jay B. Kasner and Scott D. Musoff, SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP, New York, New York; Attorneys for Defendant.

MONTGOMERY-REEVES, Vice Chancellor.

2 This case involves two demands to inspect the books and records of a

pharmacy benefit management company. The plaintiffs seek numerous books

and records to investigate potential mismanagement based on pleadings in

other legal actions involving the defendant company and public statements

made by the company’s management. The defendant company argues that

one of the plaintiff’s demands is improper and does not meet the form and

manner requirements of the statute. The defendant further argues that both

demands have an improper purpose and lack a credible basis to infer

wrongdoing. Defendant also challenges the broad scope of the inspection

demands.

This memorandum opinion contains my findings and conclusions

following a one-day trial. For the reasons discussed herein, I find that one

plaintiff’s demand does not meet the form and manner requirements;

therefore, he is not entitled to inspection. The other plaintiff’s demand meets

the form and manner requirements, states a proper purpose, and entitles him

to inspect all books and records necessary and sufficient to investigate

potential managerial wrongdoing.

3 I. BACKGROUND

These are my findings of fact after a one-day trial based on the parties’

stipulations and 74 exhibits. I accord the evidence the weight and credibility

I find it deserves.1

A. The Parties and Relevant Non-Parties

Plaintiff Clifford Elow has been a stockholder of Express Scripts

Holding Company (“Express Scripts” or the “Company”) since April 2012.2

Plaintiff Amitkumar Khandhar also purports to own Express Scripts stock.

Defendant Express Scripts is a Delaware corporation headquartered in

St. Louis, Missouri. Express Scripts provides pharmacy benefit management

(“PBM”) services. David Queller is the Senior Vice President of Sales and

Account Management for Express Scripts. George Paz is the former

Chairman and Chief Executive Officer of Express Scripts. Tim Wentworth is

President of Express Scripts.

1 After being identified initially, individuals are referenced herein by their surnames without regard to formal titles such as “Dr.” No disrespect is intended. Exhibits are cited as “JX #,” and facts drawn from the parties’ Joint Pre-Trial Stipulation and Order are cited as “PTO ¶ #.” Unless otherwise indicated, citations to the parties’ briefs are to post-trial briefs. 2 PTO ¶ 2.

4 Non-party Anthem, Inc. (“Anthem”), previously WellPoint, Inc.

(“WellPoint”), is Express Scripts’s largest commercial client. Non-party

Express Scripts, Inc. (“ESI”) is a wholly-owned subsidiary of Express Scripts.

B. The Anthem Relationship In 2009, Express Scripts entered into a ten-year contract with Anthem

to provide PBM services to certain Anthem health plans. Anthem is a large

client for ESI in the PBM services space. Revenues from the contract

represented approximately 12.2%, 14%, 16.6%, 17%, and 18% of Express

Scripts’s consolidated revenue for the years 2013, 2014, 2015, 2016, and the

three months ended March 31, 2017, respectively. Anthem’s contribution to

the Company’s profitability is expected to “continue to increase . . . as the

contract nears its termination in 2019.”3

Section 3.1(a) of the Anthem contract requires ESI to “perform services

under the Agreement ‘in a prudent and expert manner in accordance with this

Agreement and all Laws.’”4 The agreement also creates a “periodic pricing

review” procedure, which gives Anthem the ability to propose adjustments to

3 Letter to Vice Chancellor Montgomery-Reeves Ex. B, at 27 (April 26, 2017) (Express Scripts Form 10-Q for Quarter ended March 31, 2017) (hereinafter “Letter”); JX 44, at 72. 4 JX 22, ¶ 6.

5 the pricing schedule every three years. 5 Section 5.6 of the agreement

provides:

[Anthem] or a third party consultant retained by Anthem will conduct a market analysis every three (3) years during the Term of this Agreement to ensure that [Anthem] is receiving competitive benchmark pricing. In the event [Anthem] or its third party consultant determines that such pricing terms are not competitive, [Anthem] shall have the ability to propose renegotiated pricing terms to [ESI] and [Anthem] and [ESI] agrees to negotiate in good faith over the proposed new pricing terms. Notwithstanding the foregoing, to be effective any new pricing must be agreed to by [ESI] in writing.6

In 2012, ESI and Anthem reached an agreement after Anthem’s first periodic

pricing review.7

In 2015, Express Scripts and Anthem started the same negotiation

process in anticipation of the 2015 pricing review.8 Aware of this process

through comments made by Anthem, analysts began asking Express Scripts

questions about the Anthem contract and relationship.9 On February 25, 2015,

during an investor call, Queller stated that Express Scripts had

5 PTO ¶ 5. 6 Id. 7 JX 37, at 4. 8 Id.; JX 78, at 5. 9 JX 37, at 4; JX 25, ¶ 192.

6 a great relationship with Anthem. We’re right now working with them very closely to help them prepare for their 1/1/16 business . . . [o]ur teams work together closely each and every day. The relationship is very, very solid. . . . we don’t think that it’s appropriate to talk out in public about our relationship from that regard. And we look forward to having them as a client through the end of the contract term which is at the end of 2019.10

On July 29, 2015, during a second-quarter earnings call, Wentworth

stated that Express Scripts continued “close collaboration” with its clients and

that “performance to date and the positive feedback we continue to receive

gives us confidence that we will have strong retention across the board.”11

During the third-quarter earnings call on October 28, 2015, Wentworth stated

that the Company’s “strong client relationship positions us well for 2016” and

“based on our results this year, we are confident about next year’s selling and

retention season.”12 Paz, the Chairman of the board at that time, was present

on all of the relevant calls.13

10 JX 75, at 2; JX 33, at 33. 11 JX 75, at 2; JX 35, at 4. 12 JX 75, at 3; JX 36, at 5. 13 JX 33, at 2; JX 35, at 2; JX 36, at 2.

7 C. Litigation Ensues

The second renegotiation did not go as well as the first. On March 21,

2016, Anthem initiated litigation in the United States District Court for the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Skoglund v. Ormand Industries, Inc.
372 A.2d 204 (Court of Chancery of Delaware, 1976)
H-M Wexford LLC v. Encorp, Inc.
832 A.2d 129 (Court of Chancery of Delaware, 2003)
Seinfeld v. Verizon Communications Inc.
873 A.2d 316 (Court of Chancery of Delaware, 2005)
In Re General Motors (Hughes) Shareholder Litigation
897 A.2d 162 (Supreme Court of Delaware, 2006)
CM & M GROUP, INC. v. Carroll
453 A.2d 788 (Supreme Court of Delaware, 1982)
Nodana Petroleum Corporation v. State
123 A.2d 243 (Supreme Court of Delaware, 1956)
In Re Santa Fe Pacific Corp. Shareholder Litigation
669 A.2d 59 (Supreme Court of Delaware, 1995)
Seinfeld v. Verizon Communications, Inc.
909 A.2d 117 (Supreme Court of Delaware, 2006)
Security First Corp. v. U.S. Die Casting & Development Co.
687 A.2d 563 (Supreme Court of Delaware, 1997)
Thomas & Betts Corp. v. Leviton Manufacturing Co.
681 A.2d 1026 (Supreme Court of Delaware, 1996)
Melzer v. CNET Networks, Inc.
934 A.2d 912 (Court of Chancery of Delaware, 2007)
Wal-Mart Stores, Inc. v. AIG Life Insurance
860 A.2d 312 (Supreme Court of Delaware, 2004)
United Technologies Corp. v. Treppel
109 A.3d 553 (Supreme Court of Delaware, 2014)
Amalgamated Bank v. Yahoo! Inc.
132 A.3d 752 (Court of Chancery of Delaware, 2016)
Central Laborers Pension Fund v. News Corp.
45 A.3d 139 (Supreme Court of Delaware, 2012)
In re Morton's Restaurant Group, Inc. Shareholders Litigation
74 A.3d 656 (Court of Chancery of Delaware, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Clifford Elow v. Express Scripts Holding Co. and Amitkumar Khandhar v. Express Scripts Holding Co., Counsel Stack Legal Research, https://law.counselstack.com/opinion/clifford-elow-v-express-scripts-holding-co-and-amitkumar-khandhar-v-delch-2017.